NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.6080
-0.0020 (-0.33%)
At close: Mar 28, 2025, 4:00 PM
0.6000
-0.0080 (-1.32%)
After-hours: Mar 28, 2025, 7:58 PM EST
NovaBay Pharmaceuticals Employees
As of December 31, 2023, NovaBay Pharmaceuticals had 26 total employees, including 24 full-time and 2 part-time employees. The number of employees decreased by 7 or -21.21% compared to the previous year.
Employees
26
Change (1Y)
-7
Growth (1Y)
-21.21%
Revenue / Employee
$532,462
Profits / Employee
-$637,115
Market Cap
2.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NBY News
- 23 days ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 2 months ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire
- 3 months ago - NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - Business Wire
- 3 months ago - NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - Business Wire
- 4 months ago - NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024 - Business Wire
- 4 months ago - Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand - Business Wire
- 5 months ago - NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results - Business Wire
- 5 months ago - NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price - Business Wire